Design and construction of an artificial pathway for biosynthesis of acetaminophen in Escherichia coli

Xiaolin Shen,Xin Chen,Jian Wang,Xinxiao Sun,Sifan Dong,Yang Li,Yajun Yan,Jia Wang,Qipeng Yuan

DOI: https://doi.org/10.1016/j.ymben.2021.09.001

IF: 8.4

2021-11-01

Metabolic Engineering

Abstract:Acetaminophen (AAP) is one of the most commonly used drug ingredients that possesses antipyretic and analgesic effects. As an unnatural chemical, AAP is commercially produced by chemical processes using petroleum-derived carbohydrates, such as phenol, as raw materials, which is unsustainable and eco-unfriendly. In this study, we report design and construction of an artificial biosynthetic pathway for de novo production of AAP from simple carbon source. By exploring and expanding the substrate repertoire of natural enzymes, we identified and characterized a novel p-aminobenzoic acid (p-ABA) monooxygenase and an p-aminophenol (p-AP) N-acetyltransferase, which enabled the bacterial production of AAP from p-ABA. Then, we constructed an p-ABA over-producer by screening of p-ABA synthases and enhancing glutamine availability, resulting in 836.43 mg/L p-ABA in shake flasks in E. coli. Subsequent assembly of the entire biosynthetic pathway permitted the de novo production of AAP from glycerol for the first time. Finally, pathway engineering by dynamically regulating the expression of pathway genes via a temperature-inducible controller enabled production enhancement of AAP with a titer of 120.03 mg/L. This work not only constructs a microbial platform for AAP production, but also demonstrates design and construction of artificial biosynthetic pathways via discovering novel bioreactions based on existing enzymes.

biotechnology & applied microbiology

What problem does this paper attempt to address?

This paper aims to solve the problem of how to produce acetaminophen (AAP) from simple carbon sources (such as glycerol) through microbial pathways. Currently, AAP is mainly produced through a chemical synthesis process using fossil - based compounds as raw materials. This method is not only unsustainable but also environmentally unfriendly. Therefore, the researchers designed and constructed a brand - new biosynthesis pathway for de novo production of AAP in Escherichia coli.

Specifically, the paper addresses the following key issues:
1. **Enzyme selection and characterization**: The researchers need to find enzymes that can catalyze specific reactions, especially monooxygenase that can convert p - aminobenzoic acid (p - ABA) into p - aminophenol (p - AP), and N - acetyltransferase that can further convert p - AP into AAP.
2. **Overproduction of p - ABA**: To ensure sufficient supply of p - ABA, the researchers screened different p - ABA synthases and enhanced the availability of glutamine, and finally achieved a p - ABA yield of 836.43 mg/L in shake flasks.
3. **Assembly of the entire biosynthesis pathway**: The researchers integrated the above - mentioned enzymes into a complete biosynthesis pathway and achieved the direct production of AAP from glycerol for the first time.
4. **Pathway engineering optimization**: By dynamically regulating the expression of pathway genes (for example, using a temperature - induced controller), the researchers further increased the AAP yield to 120.03 mg/L.

In conclusion, this study not only constructed a microbial platform for AAP production but also demonstrated how to design and construct artificial biosynthesis pathways by discovering new biological reactions of existing enzymes. This opens up new possibilities for large - scale bio - manufacturing of AAP using renewable carbon sources in the future.